About Guangxi Wuzhou Zhongheng Group Company

The company was founded in 1993 and listed on the Shanghai Stock Exchange in 2000. It is controlled by Guangxi Investment Group Co., Ltd., the first “Fortune 500” enterprise in Guangxi, and itself controls 28 participating companies. It is one of the top 100 Chinese medicine enterprises, the top 100 Chinese medicine enterprises, and the second batch of pilot enterprises for the integrated development of advanced manufacturing and modern service industries in the country. The company has pharmaceutical manufacturing as its core leading industry, and its business covers fields such as pharmaceutical manufacturing, health consumption, pharmaceutical research and development, traditional Chinese medicine resources, Japanese cosmetics, and pharmaceutical distribution. The main products include injectable thrombotron (freeze-dried), Zhonghua Damping Pills, Gynecomasite Tablets, Yanjianning Pills, Angong Niuhuang Pills, Snake Tan Chuanbei Liquid, Fluorescein Sodium Injection, etc., and owns famous trademarks such as “Zhonghua” and “Morning Bell.” Company Honors: National High-tech Enterprise, National Intellectual Property Demonstration Enterprise, ranked among the top 100 Chinese pharmaceutical industry and the top 100 Chinese medicine companies, selected as the country's second batch of advanced manufacturing and modern service industry integrated development pilot enterprises, “Guangxi Double Hundred Action” enterprises, “Excellent Pharmaceutical Product Brands in China's Chemical Pharmaceutical Industry”, “Single Champion Product in Manufacturing (2019-2021)”, “2021 China Industry-University-Research Cooperation Innovation and Promotion Award”, and “Chinese Time-honored Brand”.